CompletedNot Applicable

Nasal Intermittent Positive Pressure Ventilation During Neonatal Intubation

Turkey (Türkiye)146 participantsStarted 2023-05-01

Plain-language summary

The study aims to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without physiological instability during all intubation attempts. The present study was designed as a prospective, multicenter, randomized, controlled study conducted with neonates undergoing endotracheal intubation. The infants were assigned randomly to either the NIPPV group or the standard care group.

Who can participate

Age range1 Day – 28 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infants of a gestational age of 22-41 weeks and undergoing oral endotracheal intubation in the neonatal intensive care within the first 28 days of life Exclusion Criteria: * The infants who required urgent intubation, * Infants intubated in the delivery room or the operating room, * Infants with a heart rate of \<120/min prior to randomization, * Infants with airway or lung anomalies, * Infants with cyanotic congenital heart disease, * Infants NIPPV treatment was contraindicated (congenital nasal anomaly, congenital diaphragmatic hernia, or abdominal wall defect)

What they're measuring

Successful intubation without physiological instability during all intubation attempts

Timeframe: One year

Trial details

NCT IDNCT06549283

SponsorMuğla Sıtkı Koçman University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-01

View on ClinicalTrials.gov More Respiratory Distress Syndrome trials